264 related articles for article (PubMed ID: 25456097)
1. Leptin in nonalcoholic fatty liver disease: a narrative review.
Polyzos SA; Kountouras J; Mantzoros CS
Metabolism; 2015 Jan; 64(1):60-78. PubMed ID: 25456097
[TBL] [Abstract][Full Text] [Related]
2. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
[TBL] [Abstract][Full Text] [Related]
3. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
Hannah WN; Harrison SA
Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.
Viglino D; Jullian-Desayes I; Minoves M; Aron-Wisnewsky J; Leroy V; Zarski JP; Tamisier R; Joyeux-Faure M; Pépin JL
Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28596431
[TBL] [Abstract][Full Text] [Related]
6. Adipokines in nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Mantzoros CS
Metabolism; 2016 Aug; 65(8):1062-79. PubMed ID: 26725002
[TBL] [Abstract][Full Text] [Related]
7. 20 years of leptin: leptin in common obesity and associated disorders of metabolism.
DePaoli AM
J Endocrinol; 2014 Oct; 223(1):T71-81. PubMed ID: 24973357
[TBL] [Abstract][Full Text] [Related]
8. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H; Moschen A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Tiopronin in treatment of severe non-alcoholic fatty liver disease.
Tang MC; Cheng L; Qiu L; Jia RG; Sun RQ; Wang XP; Hu GY; Zhao Y
Eur Rev Med Pharmacol Sci; 2014; 18(2):160-4. PubMed ID: 24488902
[TBL] [Abstract][Full Text] [Related]
10. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
11. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
Yki-Järvinen H
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
[TBL] [Abstract][Full Text] [Related]
12. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G
Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253
[TBL] [Abstract][Full Text] [Related]
13. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids and non-alcoholic fatty liver disease.
Woods CP; Hazlehurst JM; Tomlinson JW
J Steroid Biochem Mol Biol; 2015 Nov; 154():94-103. PubMed ID: 26241028
[TBL] [Abstract][Full Text] [Related]
15. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
[TBL] [Abstract][Full Text] [Related]
16. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
17. Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.
Makri ES; Evripidou K; Polyzos SA
J Gastroenterol Hepatol; 2024 May; 39(5):806-817. PubMed ID: 38238084
[TBL] [Abstract][Full Text] [Related]
18. Weight loss as a treatment for nonalcoholic fatty liver disease.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
[TBL] [Abstract][Full Text] [Related]
20. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
